| |
| |
|
| Insider
Information: |
Beetham Thomas W. |
| Relationship: |
See Remarks |
| City: |
Hamilton |
| State: |
D0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
317,420 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,824,544 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
317,420 |
|
|
| Total
Value |
$5,824,544 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -77.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
EVP & Chief Legal Offi... |
2021-02-03 |
297,523 |
2018-05-29 |
0 |
Premium* |
|
|
Dianthus Therapeutics Ord Shs |
DNTH |
See Remarks |
2022-11-30 |
19,897 |
2021-09-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNTH |
Dianthus Therapeutics Ord... |
See Remarks |
• – – |
2022-11-30 |
4 |
A |
$0.94 |
$2,820 |
D/D |
3,000 |
19,897 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
See Remarks |
• – – |
2022-05-31 |
4 |
A |
$0.99 |
$2,970 |
D/D |
3,000 |
16,897 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
See Remarks |
• – – |
2021-09-16 |
4 |
S |
$6.73 |
$41,073 |
D/D |
(6,103) |
13,897 |
0 |
% |
|
| DNTH |
Dianthus Therapeutics Ord... |
See Remarks |
• – – |
2021-09-14 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
EVP & Chief Legal Officer |
• – – |
2021-02-03 |
4 |
AS |
$22.09 |
$54,717 |
D/D |
(2,477) |
297,523 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
EVP & Chief Legal Officer |
• – – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
300,000 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
EVP & Chief Legal Officer |
• – – |
2020-07-01 |
4 |
AS |
$25.32 |
$750,678 |
D/D |
(29,589) |
0 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
EVP & Chief Legal Officer |
• – – |
2020-06-10 |
4 |
AS |
$25.07 |
$344,763 |
D/D |
(13,752) |
29,589 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
EVP & Chief Legal Officer |
• – – |
2020-06-10 |
4 |
OE |
$1.59 |
$21,866 |
D/D |
13,752 |
43,341 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
EVP & Chief Legal Officer |
• – – |
2020-04-21 |
4 |
AS |
$19.56 |
$50,092 |
D/D |
(2,518) |
29,589 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
EVP & Chief Legal Officer |
• – – |
2020-04-20 |
4 |
AS |
$19.06 |
$903,882 |
D/D |
(47,423) |
32,107 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
EVP & Chief Legal Officer |
• – – |
2020-02-14 |
4 |
AS |
$18.58 |
$1,096 |
D/D |
(59) |
79,530 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Legal Officer |
• – – |
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,392 |
79,589 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
